A5047565271- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Microbial Inactivation Methods
- Acute Ischemic Stroke Management
- Electrostatic Discharge in Electronics
- Cardiac tumors and thrombi
Klinički Bolnički Centar Split
2022-2024
University Hospital Centre Zagreb
2024
University of Split
2023-2024
Pulsed field ablation (PFA) has emerged as a promising alternative to thermal for treatment of atrial fibrillation (AF). We report performance and safety using the CENTAURI™ System (Galvanize Therapeutics) with three commercial, focal catheters.ECLIPSE AF (NCT04523545) was prospective, single-arm, multi-centre study evaluating acute chronic pulmonary vein isolation (PVI) durability CENTAURI in conjunction TactiCath SE, StablePoint, ThermoCool ST catheters. Patients paroxysmal or persistent...
The unique safety profile of pulsed field ablation (PFA) has made pulmonary vein isolation (PVI) + left atrial posterior wall (LAPW) promising for treating persistent fibrillation (PerAF). goal this study was to assess long-term freedom from fibrillation, flutter, and tachycardia (AF/AFL/AT), as well the feasibility LAPW PFA using multipolar, pentaspline Farawave catheter.
Abstract Aims Patients with atrial fibrillation who despite taking oral anti-coagulant therapy (OAT) suffer a stroke or systemic embolism (SSE) without vascular cause develop left appendage (LAA) thrombus (LAAT) should be considered as having malignant LAA. The optimal treatment strategy to reduce SSE risk in such patients is unknown. aim of the study investigate diagnostic and therapeutic pathways for LAA practiced European cardiac centres. Methods results An 18-item online questionnaire on...
BACKGROUND: Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. We report 1-year freedom from arrhythmia outcomes using monopolar PFA delivered through 3 commercial, contact force–sensing focal catheters. METHODS: ECLIPSE AF (NCT04523545) was prospective, single-arm, multicenter study evaluating acute and chronic safety performance the CENTAURI system to deliver with TactiCath SE, StablePoint, ThermoCool ST. Patients paroxysmal or persistent fibrillation underwent...
Uvod: Fibrilacija atrija (FA) jedan je od čimbenika rizika za ishemijski moždani udar (MU) koji moguće prevenirati.Visoka prevalencija te mogućnost prevencije upućuju na potrebu učinkovitim načinom detekcije FA-a.Cilj ovog istraživanja bio procijeniti prevalenciju i način dijagnoze FA-a u bolesnika s ishemijskim MU usporediti njihova klinička